Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?

Cancer

Volumn 110, Issue 6, 2007, Pages 1235-1240

  Beck, Stephen D W ^a,b   Foster, Richard S ^a   Bihrle, Richard ^a   Donohue, John P ^a   Einhorn, Lawrence H ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Indiana Cancer Pavilion   (United States)

Author keywords

Modified; Retroperitoneal lymph node dissection; Teratoma; Testicular cancer

Indexed keywords

CISPLATIN; TUMOR MARKER;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NECROSIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; RECURRENT DISEASE; RETROPERITONEAL TUMOR; REVIEW; TERATOMA; TESTIS CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 34548780893     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22898     Document Type: Review

References (8)

1. Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982;128:315-320.
2. Foster RS, Donohue JP, Bihrle R. Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy. Urol Int. 1991;46:294-297.
3. Stephenson AJ, Bosl GJ, Motzer RJ, et al. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol. 2005;23:2781-2788.
4. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 1997;15:594-603.
5. Donohue JP, Leviovitch I, Foster RS, Baniel J, Tognoni R Integration of surgery and systemic therapy: results and principles of integration. Semin Urol Oncol. 1988;16:65-71.
6. Wood DP Jr, Herr HW, Heller G, et al. Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol. 1992;148: 1812-1815; discussion 1815-1816.
7. Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol. 1998;81:295-300.
8. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol. 2003;21:3310-3317.